Benjamin F. Edwards & Company’s Elanco Animal Health ELAN Stock Holding History

Benjamin F. Edwards & Company’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$26K	Buy	1,764 +1,361	+338%	+$21.7K	﹤0.01%	1478
2024 Q1	$7K	Sell	403 -106	-21%	-$1.66K	﹤0.01%	1769
2023 Q4	$8K	Hold	509	–	–	﹤0.01%	1716
2023 Q3	$6K	Hold	509	–	–	﹤0.01%	1502
2023 Q2	$5K	Sell	509 -220	-30%	-$2.04K	﹤0.01%	1540
2023 Q1	$7K	Sell	729 -995	-58%	-$11.7K	﹤0.01%	1465
2022 Q4	$21K	Sell	1,724 -495	-22%	-$6.17K	﹤0.01%	1272
2022 Q3	$28K	Sell	2,219 -2,936	-57%	-$51.3K	﹤0.01%	1182
2022 Q2	$101K	Sell	5,155 -118	-2%	-$2.79K	﹤0.01%	855
2022 Q1	$138K	Sell	5,273 -231	-4%	-$6.15K	0.01%	782
2021 Q4	$156K	Buy	5,504 +676	+14%	+$21K	0.01%	756
2021 Q3	$154K	Sell	4,828 -32	-0.7%	-$1.07K	0.01%	745
2021 Q2	$169K	Buy	+4,860	New	+$160K	0.01%	686
2020 Q4	–	Sell	-56	Closed	-$2K	–	1628
2020 Q3	$2K	Buy	+56	New	+$1.42K	﹤0.01%	1566
2019 Q3	–	Sell	-234	Closed	-$8K	–	1865
2019 Q2	$8K	Buy	+234	New	+$7.6K	﹤0.01%	1480

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Benjamin F. Edwards & Company's ELAN Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Elanco Animal Health (ELAN) stake by 338% in Q2 2024, buying an estimated $21.7K and bringing the position to 1,764 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #1478.

Benjamin F. Edwards & Company first reported a position in ELAN in Q2 2019 and has held it in 15 quarters since. The position peaked at $169K in Q2 2021. 402 funds tracked by Wall St. Rank hold ELAN as of Q2 2024.

Benjamin F. Edwards & Company held 1,764 shares of Elanco Animal Health worth $26K as of Q2 2024.
Benjamin F. Edwards & Company bought 1,361 Elanco Animal Health shares in Q2 2024, an estimated $21.7K.
Elanco Animal Health made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1478 holding.
Benjamin F. Edwards & Company first reported a position in Elanco Animal Health in Q2 2019 and has held it in 15 quarters since.
Benjamin F. Edwards & Company's Elanco Animal Health position peaked at $169K in Q2 2021.
402 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.